Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
23 Ansichten
• 07/30/23
0
0
Einbetten
administrator
Abonnenten
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare